Register
Healthed-White-on-Blue
Richmond, Prof Peter_V2

A/Prof Peter Richmond

Consultant Paediatric Immunologist & Paediatrician; Perth Children’s Hospital; Head of the Vaccine Trials Group, Wesfarmers Centre of Vaccines and Infectious Diseases
Professor Peter Richmond is Head of the Vaccine Trials Group which sits in the Wesfarmers Centre of Vaccines and Infectious Diseases. Professor Richmond is also a Consultant Paediatric Immunologist and Paediatrician at Perth Children’s Hospital (PCH), Head of the Department of Child Health Research, PCH and Director of the Child Health Research Network, Child and Adolescent Health Service. He also is the Head of Division of Paediatrics, School of Medicine at the University of Western Australia. Peter’s major research interests are the evaluation of new vaccines designed to prevent bacterial and viral infections in the paediatric population and understanding protective immunity infectious disease in young children.

More from this expert

Peter Richmond_Bexsero_22min.00_00_05_23.Still005
Videos iconVideos

Real-world evidence for meningococcal B vaccines and how to have MenB conversations in general practice

In this Product Explainer, Paediatrician and Paediatric Immunologist Prof Peter Richmond explains how Meningococcal serogroup B (MenB) disease remains the most common cause of IMD in children, adolescents and young adults, and provides an overview of the real-world evidence for MenB vaccines, and conversation strategies for use with families in general practice (6 mins).

doctor-563428_640

Meningitis prevention – Conversation strategies

Conversation strategies to educate patients so that they can make a realistic assessment of the cost benefit equation.

By A/Prof Peter Richmond
Podcasts iconPodcasts
Little,Girl,Receiving,Chickenpox,Vaccination,In,Clinic.,Varicella,Virus,Prevention

Prevention of meningococcal disease & meningitis in children: Conversations with parents

The incidence of meningococcal disease in Australia

By A/Prof Peter Richmond
Podcasts iconPodcasts
Peter Richmond_Bexsero_22min.00_00_05_23.Still005

Conversations on meningococcal disease with parents

In this Product Explainer, Paediatrician and Paediatric Immunologist A/Prof Peter Richmond explains which patients are most at risk for meningococcal B, the risk reduction benefits of meningococcal B vaccination and why it is important to have conversations with parents in which the risk/benefits of vaccination are clearly explained (5 mins).

By A/Prof Peter Richmond
Videos iconVideos
Peter Richmond_Bexsero_22min.00_00_05_23.Still005

Real-world evidence for meningococcal B vaccines and how to have MenB conversations in general practice

In this Product Explainer, Paediatrician and Paediatric Immunologist Prof Peter Richmond explains how Meningococcal serogroup B (MenB) disease remains the most common cause of IMD in children, adolescents and young adults, and provides an overview of the real-world evidence for MenB vaccines, and conversation strategies for use with families in general practice (6 mins).

By A/Prof Peter Richmond
Videos iconVideos
shutterstock_2083417909

Meningitis in adolescents: Health risks associated with social behaviours

The incidence of meningitis in adolescents and young people

By A/Prof Peter Richmond
Podcasts iconPodcasts

Education by clinicians, for clinicians

Get the app

Site

Company

Connect

Legal

Discover

Healthed

CPD platform